MyAverix Finance
F · Healthcare
LIPIGON PHARMA. AB (9RP)
Biotechnology
LIPIGON PHARMA. AB (9RP) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-25, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 9RP
LIPIGON PHARMA. AB (9RP) — FAQ
What is 9RP's P/E ratio?
The price-to-earnings (P/E) ratio for LIPIGON PHARMA. AB (9RP) is 18.00 (data as of 2026-03-25).
Does LIPIGON PHARMA. AB pay a dividend?
Dividend yield is not available in the current snapshot for LIPIGON PHARMA. AB (9RP). Check the MyAverix Finance app for the latest dividend data.
What sector is LIPIGON PHARMA. AB in?
LIPIGON PHARMA. AB (9RP) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 9RP listed on?
9RP is listed on F.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.